Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01667317
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ID5 | [5-FLUORO-2-({[(4,5,7-TRIFLUORO- 1,3-BENZOTHIAZOL-2-YL)METHYL]AMINO}CARBONYL)PHENOXY]ACETIC ACID | A | 1T40 | 0.8 | |
ID5 | [5-FLUORO-2-({[(4,5,7-TRIFLUORO- 1,3-BENZOTHIAZOL-2-YL)METHYL]AMINO}CARBONYL)PHENOXY]ACETIC ACID | A | 1T41 | 0.8 | |
TFL | 2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY- 3-METHYL-1,3-BENZOTHIAZOL-3-IUM | A | 2J3Q | 0.76 | |
MZ5 | (2S)-N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-2-HYDROXY- 3-METHYLBUTANAMIDE | A,B | 2QI3 | 0.74 | |
6IN | 4-(1-BENZYL-3-CARBAMOYLMETHYL-2- METHYL-1H-INDOL-5-YLOXY)-BUTYRIC ACID | A | 1DB5 | 0.72 | |
ML1 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | A,B | 2QX4 | 0.71 | |
ML1 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | A,B | 2QX6 | 0.71 | |
ML1 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | A,B | 2QWX | 0.71 | |
MZ7 | N~2~-ACETYL-N-{(1S,2R)-3-[(1,3- BENZOTHIAZOL-6-YLSULFONYL)(PENTYL)AMINO]- 1-BENZYL-2-HYDROXYPROPYL}-L-VALINAMIDE | A,B | 2QI5 | 0.71 | |
EZL | 6-ethoxy-1,3-benzothiazole-2-sulfonamide | A | 3CAJ | 0.74 | |
EZL | 6-ethoxy-1,3-benzothiazole-2-sulfonamide | A | 3DCW | 0.74 | |
EZL | 6-ethoxy-1,3-benzothiazole-2-sulfonamide | A | 3DD0 | 0.74 | |
735 | 2-METHYL-2-(4-{[({4-METHYL-2-[4- (TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL- 5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID | A | 2P54 | 0.78 | |
1FA | [(7-{[2-(3-MORPHOLIN-4-YLPROP-1- YN-1-YL)-6-{[4-(TRIFLUOROMETHYL)PHENYL]ETHYNYL}PYRIDIN- 4-YL]THIO}-2,3-DIHYDRO-1H-INDEN- 4-YL)OXY]ACETIC ACID | A,B | 2Q5G | 0.71 | |
IID | N-(1-ISOPROPYLPIPERIDIN-4-YL)-1- (3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE | A,B | 2BQ7 | 0.7 | |
1PD | 2-({3-[5-hydroxy-2-(3-methylbutyl)- 3-oxo-6-(1,3-thiazol-5-yl)-2,3- dihydropyridazin-4-yl]-1,1-dioxido- 2H-1,2,4-benzothiadiazin-7-yl}oxy)acetamide | A,B | 3BSA | 0.7 | |
TEI | 2-(3-CYANO-4-ISOBUTOXY-PHENYL)- 4-METHYL-5-THIAZOLE-CARBOXYLIC ACID | A,B | 1N5X | 0.7 | |
3LG | (5-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)- 6-OXOPIPERAZIN-2-YL]METHOXY}-1H- INDOL-1-YL)ACETIC ACID | B | 2G26 | 0.71 | |
MZ8 | N-{(1S,2R)-3-[(1,3-BENZOTHIAZOL- 6-YLSULFONYL)(ISOBUTYL)AMINO]-1- BENZYL-2-HYDROXYPROPYL}-3-HYDROXYBENZAMIDE | A,B | 2QI6 | 0.76 | |
ML2 | N-[2-(2-iodo-5-methoxy-1H-indol- 3-yl)ethyl]acetamide | A,B | 2QX9 | 0.72 | |
ML2 | N-[2-(2-iodo-5-methoxy-1H-indol- 3-yl)ethyl]acetamide | A,B | 2QX8 | 0.72 | |
MZ6 | N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-3-HYDROXYBENZAMIDE | A,B | 2QI4 | 0.75 | |
YPA | (S)-3-(4-(2-CARBAZOL-9-YL-ETHOXY)- PHENYL)-2-ETHOXY-PROPIONIC ACID | A | 1KNU | 0.7 |